Rockefeller Capital Management »

Immunic shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.5k 100 15.37

More positions owned by Rockefeller Capital Management

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Broadcom (AVGO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tidal Trust Iii Rock Gl Equi Etf (RGEF)
Tidal Trust Iii Rock Us Smal Etf (RSMC)

View all positions for Rockefeller Capital Management

Top funds holding Immunic

Standard Life Aberdeen
BVF
Millennium Management
Avidity Partners Management
Braidwell
Laurion Capital Management
Vanguard Capital Management
Jones Hill Capital
Woodline Partners
Soleus Capital Management
Propel Bio Management
Susquehanna International
Nantahala Capital Management
UBS Group
Geode Capital Management

View all funds holding Immunic